Magnesium bier's block for treatment of chronic limb pain: A randomised, double-blind, cross-over study

Pain

Volumn 99, Issue 1-2, 2002, Pages 235-241

  Tramèr, Martin R ^a   Glynn, Chris J ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Chronic limb pain; Magnesium bier's block; Treatment

Indexed keywords

CALCIUM; LIDOCAINE; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LIMB PAIN; MALE; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ANESTHETICS, LOCAL; AUTONOMIC NERVE BLOCK; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EXTREMITIES; FEMALE; HUMANS; LIDOCAINE; MAGNESIUM SULFATE; MALE; MIDDLE AGED; PAIN; TREATMENT OUTCOME;

EID: 0036711402     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00105-7     Document Type: Article

References (13)

1. 2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharm. 65:1987;729-745.
2. Bier A. Ueber einen neuen Weg Lokalananästhesie an den Gliedmassen zu erzeugen. Ver Dtsch Ges Chir. 37:1908;204.
3. Carlton S.M., Coggeshall R.E. NMDA, AMPA and kainate receptors are present in axons in the glabrous skin of the rat hindpaw. Soc Neurosci Abstr. 21:1995;356.
4. Casale R., Glynn C.J., Scarzella G. The role of the sympathetic skin response (SSR) in the investigation of patients with sympathetically maintained pain. Bond M.R., Charlton J.E., Woolf C.J., Proceedings of the Sixth World Congress on Pain. 1991;391-394 Elsevier, Amsterdam.
5. Cook R.J., Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. Br Med J. 310:1995;452-454.
6. Crosby V., Wilcock A., Corcoran R. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage. 19:2000;35-39.
7. DeBiasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of the spinal cord. Proc Natl Acad Sci USA. 85:1988;7820-7824.
8. Glynn C.J., Walsh J.A., Basedow R.W., Marzola M. A model for investigating the effect of drugs on the peripheral sympathetic nervous system in man. J Auton Nerv Syst. 5:1982;195-205.
9. Iseri L.T., French J.H. Magnesium: nature's physiologic calcium blocker. Am Heart J. 108:1984;188-194. [Editorial].
10. Lillie P.E., Glynn C.J., Fenwick D.G. Site of action of intravenous regional anesthesia. Anesthesiology. 61:1984;507-510.
11. Mantyh P.W., Allen C.J., Rogers S., DeMaster E., Ghilardi J.R., Mosconi T., Kruger L., Mannon P.J., Taylor I.L., Vigna S.R. Some sensory neurons express neuropeptide Y receptors: potential paracrine inhibition of primary afferent nociceptors following peripheral nerve injury. J Neurosci. 14:1994;3958-3968.
12. ++ of NMDA responses in spinal cord neurons. Nature. 309:1984;261-263.
13. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. J Am Med Assoc. 273:1995;408-412.